Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigulixostat vs febuxostat in Chinese patients with gout
CTR20242035Phase 2Completed
- Sponsor
- Innovent Biologics
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tigulixostat in gout, sponsored by Innovent Biologics. Started Jun 2024; status: completed.
02
Drugs
tigulixostat
03
Conditions
gout
Beyond the preview
Go deeper on CTR20242035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242035.